Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Receivables: 2011-2012

Historic Receivables for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Dec 2012 value amounting to $3.5 million.

  • Sonoma Pharmaceuticals' Receivables rose 82.67% to $3.5 million in Q4 2012 from the same period last year, while for Dec 2012 it was $12.5 million, marking a year-over-year increase of 53.23%. This contributed to the annual value of $2.5 million for FY2012, which is 19.05% up from last year.
  • Sonoma Pharmaceuticals' Receivables amounted to $3.5 million in Q4 2012, which was up 9.08% from $3.2 million recorded in Q3 2012.
  • Sonoma Pharmaceuticals' 5-year Receivables high stood at $3.5 million for Q4 2012, and its period low was $1.9 million during Q4 2011.
  • For the 2-year period, Sonoma Pharmaceuticals' Receivables averaged around $2.6 million, with its median value being $2.3 million (2011).
  • Data for Sonoma Pharmaceuticals' Receivables shows a peak YoY skyrocketed of 82.67% (in 2012) over the last 5 years.
  • Sonoma Pharmaceuticals' Receivables (Quarterly) stood at $1.9 million in 2011, then soared by 82.67% to $3.5 million in 2012.
  • Its last three reported values are $3.5 million in Q4 2012, $3.2 million for Q3 2012, and $3.3 million during Q2 2012.